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nhe OPT-CHF
Oxypurinol Therapy for
ongestive Heart Failure) Trial
Question of Dose
e read the OPT-CHF (Oxypurinol Therapy for Congestive
eart Failure) study results with interest (1). We agree with the
uthors’ comments regarding the possible reasons oxypurinol did
ot lead to clinical benefits. However, the issue of dose needs to be
mphasized further, as the urate fall from baseline with 600 mg
xypurinol in the OPT-CHF study was 26% (2.1 mg/dl [0.12
mol/l]). Our group has previously demonstrated that with
llopurinol 300 mg, a urate fall of 44% (3.0 mg/dl [0.18 mmol/l])
an be achieved; with allopurinol 600 mg, we achieved a mean
rate fall of 61% from baseline (4.2 mg/dl [0.25 mmol/l]) (2).
rucially, in this head-to-head comparison, there was a steep
ose-response curve between the dose of allopurinol and its
eneficial vascular effects (2). This dose-response was also seen in
n observational study of heart failure patients, looking at 100 mg
ersus 300 mg allopurinol (3).
These observations and the degree of urate lowering seen in the
PT-CHF study suggest that the dose of oxypurinol used was
ell below the optimum dose. In fact, at the Arthritis Advisory
ommittee Meeting of the Food and Drug Administration (FDA)
n June 2004, data from the bioequivalence AAI-US-175 study
howed that 600 mg oxypurinol had a relative bioavailability
quivalent to 81 mg allopurinol (4). That is less than the usual
tarting dose of 100 mg and 10% of the maximal FDA-allowed
ose of 800 mg.
In addition, clinical outcomes in a 6-month trial may be more
etermined by changes in volume status rather than by improve-
ents in mechanoenergetic uncoupling, left ventricular remodel-
ng, and endothelial function, which would require a longer
uration of treatment to change clinical end points, especially in an
utcome trial with only 400 patients. Despite these limitations,
xypurinol did appear to benefit high-risk patients with raised
rate levels, a finding that underscores the need for larger studies
sing larger doses.
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oronary Angiography:
atheter Based or Computed
omography Based
read with interest the paper by Meijboom et al. (1) relating to
iagnostic accuracy of 64-slice computed tomographic coronary
ngiography (CTA) and the editorial comment on the limitations
f CTA by Nissen (2).
Bluemke et al. (3), in a scientific statement on noninvasive
oronary artery imaging, remind us that CTA gives one no option
or immediate intervention, does not serve as the only basis for
oronary artery bypass grafting (CABG), has no outcome analyses,
as angiographic comparisons with small groups pre-selected to
ndergo both procedures, and has lower spatial resolution com-
ared to catheter-based coronary angiography (CBCA); in addi-
ion, motion and other artifacts may result in false-negative and
alse-positive results with CTA, and continuous visualization of
he coronaries with CTA is not possible at present on patients with
trial fibrillation or frequent ectopy.
Further limitations as outlined by Nissen (2) are as follows:
hen CTA is used to visualize the coronary arteries, calcification
f the coronaries can cause false-negative and false-positive results,
tents make visualization of the coronary lumen difficult, and the
redominant risk of CTA is radiation exposure. However, I am
old by CTA advocates that radiation reduction strategies such as
ube modulation or prospectively ECG-triggered acquisitions are
n the horizon (4).
I have no doubt that CTA will become a useful, but limited,
iagnostic imaging device for coronary artery assessment. How-
ver, I would like to point out some of the positive values of CBCA
ince it has been and remains the standard of reference for coronary
oninvasive imaging techniques.
CBCA provides assessment about stenosis percent narrowing,
ocation, morphology, and condition of the distal vessel, stenosis
n
T
T
i
w
t
p
m
m
b
t
a
c
c
t
i
C
m
m
o
a
c
p
c
o
w
n
i
d
t
*
*
H
1
P
G
E
R
1
2
3
4
R
A
m
D
b
e
c
t
r
c
d
t
p
l
i
O
I
e
o
g
n
t
*
*
C
H
P
R
t
E
R
1
2406 Correspondence JACC Vol. 53, No. 25, 2009
June 23, 2009:2405–6umber in the same vessel, number of vessels containing stenoses,
hrombolysis In Myocardial Infarction (TIMI) flow grade, and
IMI myocardial perfusion grade. It also provides access for
ntracoronary ultrasound, optical coherence tomography (vascular
all evaluation), coronary flow reserve (microcirculation evalua-
ion), and fractional flow reserve (epicardial stenosis evaluation).
CBCA also can detect minimal irregularities (such as plaque
rone to rupture). Collateral flow is easily detected with this
ethod as are coronary artery anomalies as well as evaluation of
icrocirculation by assessment of myocardial blush and collateral
lood flow. With the catheters in place, one can obtain informa-
ion about regional and global ventricular function, valves can be
ssessed, and pressures measured.
CBCA is useful for the detection of myocardial bridges and
oronary artery spasm, physiologic investigation of the coronary
irculation, detection of coronary artery dissections, and their
herapy. Coronary artery calcium seen at fluoroscopy does not
nterfere with the detection of coronary stenoses an angiography.
oronary angiography also provides information about regional
yocardial viability by the assessment of TIMI flow grade, TIMI
yocardial blush grade, and left ventricular regional wall motion
n ventriculography.
With catheters in the heart, the coronary venous circulation may
lso be assessed, either by runoff from the coronary arteries or by direct
atheterization of the coronary sinus with retrograde coronary venous
erfusion possibly useful in biventricular pace implantation.
I would add to this that oftentimes when pictures of CTA are
ompared to pictures of CBCA, only a single view and single frame
f the catheter-based angiogram is shown. This is not the real
orld of coronary angiography. No one looks at a single frame, and
o one looks in one single projection to assess coronary pathology.
Finally, all things considered, properly done cardiac catheter-
zation with contrast angiography can be a 1-stop shop for
iagnostic imaging and therapy of the cardiovascular system, and
he radiation dose is acceptable.
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eply
s a practicing coronary angiographer and interventionalist for
any years, I appreciate, respect, and agree with the comments of
r. Conti regarding our recent paper (1). The virtues of catheter-
ased coronary angiography, so well presented in his letter to the
ditor, are many, and the majority of the opportunities of invasive
oronary angiography cannot be replaced by a noninvasive imaging
echnique such as computed tomography (CT) coronary angiog-
aphy. But I do not entirely agree with the notion that CT
oronary angiography will become a useful but “limited” imaging
evice for coronary assessment. At the current stage of CT
echnology, it definitely falls short of invasive coronary angiogra-
hy, but new detector technology has improved the spatial reso-
ution to reduce the gap between the diagnostic accuracy of
nvasive coronary angiography and CT coronary angiography.
bviously, the dynamic nature of Thrombolysis In Myocardial
nfarction flow grade, myocardial blush, and assessment of collat-
rals, as well as pressure measurements will remain in the domain
f invasive coronary angiography, whereas invasive coronary an-
iography is an indispensable roadmap for intracoronary diag-
ostic devices and invasive catheter-based coronary obstruction
reatment.
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